Eli Lilly & Co. Inc. said Tuesday the Japanese regulator has approved its Kisunla treatment for adults with early symptomatic Alzheimer’s disease, including those with mild cognitive impairment ...

It’s a problem—but one that’s easily solvable. In-wall smart outlets look and function like ordinary electrical outlets, yet are remote controllable and can also give you the power to ...

Eli Lilly’s two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition. These players ...

Indian-origin Pulitzer Prize-winning author Jhumpa Lahiri, has declined the prestigious 2024 Isamu Noguchi Award in protest of the Noguchi Museum’s recently implemented dress code policy. Lahiri’s ...

Donanemab, manufactured by Eli Lilly (LLY), is the latest in a new class of anti-amyloid drugs that deliver antibodies to target beta-amyloid, a protein linked to Alzheimer's disease. Initially ...

The most recent trading session ended with Eli Lilly (LLY) standing at $909.32, reflecting a -1.65% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.4%.

Pulitzer Prize-winning author Jhumpa Lahiri declined to accept an award from New York City's Noguchi Museum after it fired three employees for wearing keffiyeh head scarves, an emblem of ...

The Associated Press, whose election calls are widely amplified by major media outlets, has determined it needs to devote more people and other resources to explain its decisions to readers.

Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure they stay there as competition enters, the companies are spending billions in ...

Happy first week of fall! With the changing season comes a fresh wave of deals on Amazon, especially in the hidden gem that is the Amazon Outlet. Packed with overstock and clearance items ...

Sept 24 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment ...

The United States Space Force is partnering with the Indian government to establish a new factory that will manufacture semiconductors, which are microchips essential for building next-generation ...